CRIT REV ONCOL HEMAT 润色咨询

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

出版年份:1983 年文章数:1913 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2242612, encodeId=867e22426124f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:记录一下,这个杂志社只收综述,而且整个过程会很慢,一切尽在不言中。<br>5.26投稿<br>5.29with editor<br>6.12还是with editor(发邮件催了一下)<br>7.2 under review(然后就有卡这了,发邮件催了2次还结果)<br>9月10号没想到突然就给了小修<br>9.22返修回去,一直with editor(都要放弃了,搞的都没脾气了)<br>最终11.12 accept。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822136, createdTime=Sun Dec 15 14:38:48 CST 2024, time=2024-12-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2249266, encodeId=ce5322492662a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:文章成功接收 分享下经验 <br>投稿类型:综述 实体瘤<br>12.4 submission<br>12.5 Send emails every day, modify the format, and then always with editor<br>12.14 Status updated around the day (date updated) Status is still with editor<br>12.16 under review 编辑邀请30+审稿人 有三位审稿人接收<br>1.9日 收到邮件 要求小修 审稿人十分友好 <br>1.20日提交返修<br>1.22文章接收<br>总体来说 这个杂志的速度是很快的 主编和审稿人非常友好!整个过程十分友好! 祝大家早日收到好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Thu Jan 23 09:20:06 CST 2025, time=2025-01-23, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2244413, encodeId=d21e22444132c, content=大家一般几位审稿人呀<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Sun Dec 22 23:22:43 CST 2024, time=2024-12-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2226088, encodeId=d04a2226088be, content=偏重的研究方向:肿瘤;实体肿瘤<br>经验分享:这杂志编辑去哪里了?with editor两个月没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54b86386942, createdName=ms9000000642329370, createdTime=Mon Sep 16 17:38:15 CST 2024, time=2024-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2242220, encodeId=6a1722422200c, content=状态记录12.05 with editor 至今仍然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Fri Dec 13 10:27:58 CST 2024, time=2024-12-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0<br>偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor状态持续两个半月,然后直接拒稿,白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京)]
    2024-12-15 ms3000001788822136 来自上海

    审稿速度:12.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:记录一下,这个杂志社只收综述,而且整个过程会很慢,一切尽在不言中。
    5.26投稿
    5.29with editor
    6.12还是with editor(发邮件催了一下)
    7.2 under review(然后就有卡这了,发邮件催了2次还结果)
    9月10号没想到突然就给了小修
    9.22返修回去,一直with editor(都要放弃了,搞的都没脾气了)
    最终11.12 accept。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2242612, encodeId=867e22426124f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:记录一下,这个杂志社只收综述,而且整个过程会很慢,一切尽在不言中。<br>5.26投稿<br>5.29with editor<br>6.12还是with editor(发邮件催了一下)<br>7.2 under review(然后就有卡这了,发邮件催了2次还结果)<br>9月10号没想到突然就给了小修<br>9.22返修回去,一直with editor(都要放弃了,搞的都没脾气了)<br>最终11.12 accept。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822136, createdTime=Sun Dec 15 14:38:48 CST 2024, time=2024-12-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2249266, encodeId=ce5322492662a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:文章成功接收 分享下经验 <br>投稿类型:综述 实体瘤<br>12.4 submission<br>12.5 Send emails every day, modify the format, and then always with editor<br>12.14 Status updated around the day (date updated) Status is still with editor<br>12.16 under review 编辑邀请30+审稿人 有三位审稿人接收<br>1.9日 收到邮件 要求小修 审稿人十分友好 <br>1.20日提交返修<br>1.22文章接收<br>总体来说 这个杂志的速度是很快的 主编和审稿人非常友好!整个过程十分友好! 祝大家早日收到好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Thu Jan 23 09:20:06 CST 2025, time=2025-01-23, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2244413, encodeId=d21e22444132c, content=大家一般几位审稿人呀<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Sun Dec 22 23:22:43 CST 2024, time=2024-12-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2226088, encodeId=d04a2226088be, content=偏重的研究方向:肿瘤;实体肿瘤<br>经验分享:这杂志编辑去哪里了?with editor两个月没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54b86386942, createdName=ms9000000642329370, createdTime=Mon Sep 16 17:38:15 CST 2024, time=2024-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2242220, encodeId=6a1722422200c, content=状态记录12.05 with editor 至今仍然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Fri Dec 13 10:27:58 CST 2024, time=2024-12-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0<br>偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor状态持续两个半月,然后直接拒稿,白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京)]
    2025-01-23 ms1000000794282034 来自湖南省

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享:文章成功接收 分享下经验
    投稿类型:综述 实体瘤
    12.4 submission
    12.5 Send emails every day, modify the format, and then always with editor
    12.14 Status updated around the day (date updated) Status is still with editor
    12.16 under review 编辑邀请30+审稿人 有三位审稿人接收
    1.9日 收到邮件 要求小修 审稿人十分友好
    1.20日提交返修
    1.22文章接收
    总体来说 这个杂志的速度是很快的 主编和审稿人非常友好!整个过程十分友好! 祝大家早日收到好消息

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2242612, encodeId=867e22426124f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:记录一下,这个杂志社只收综述,而且整个过程会很慢,一切尽在不言中。<br>5.26投稿<br>5.29with editor<br>6.12还是with editor(发邮件催了一下)<br>7.2 under review(然后就有卡这了,发邮件催了2次还结果)<br>9月10号没想到突然就给了小修<br>9.22返修回去,一直with editor(都要放弃了,搞的都没脾气了)<br>最终11.12 accept。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822136, createdTime=Sun Dec 15 14:38:48 CST 2024, time=2024-12-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2249266, encodeId=ce5322492662a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:文章成功接收 分享下经验 <br>投稿类型:综述 实体瘤<br>12.4 submission<br>12.5 Send emails every day, modify the format, and then always with editor<br>12.14 Status updated around the day (date updated) Status is still with editor<br>12.16 under review 编辑邀请30+审稿人 有三位审稿人接收<br>1.9日 收到邮件 要求小修 审稿人十分友好 <br>1.20日提交返修<br>1.22文章接收<br>总体来说 这个杂志的速度是很快的 主编和审稿人非常友好!整个过程十分友好! 祝大家早日收到好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Thu Jan 23 09:20:06 CST 2025, time=2025-01-23, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2244413, encodeId=d21e22444132c, content=大家一般几位审稿人呀<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Sun Dec 22 23:22:43 CST 2024, time=2024-12-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2226088, encodeId=d04a2226088be, content=偏重的研究方向:肿瘤;实体肿瘤<br>经验分享:这杂志编辑去哪里了?with editor两个月没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54b86386942, createdName=ms9000000642329370, createdTime=Mon Sep 16 17:38:15 CST 2024, time=2024-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2242220, encodeId=6a1722422200c, content=状态记录12.05 with editor 至今仍然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Fri Dec 13 10:27:58 CST 2024, time=2024-12-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0<br>偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor状态持续两个半月,然后直接拒稿,白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京)]
    2024-12-22 ms1000000794282034 来自湖南省

    大家一般几位审稿人呀

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2242612, encodeId=867e22426124f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:记录一下,这个杂志社只收综述,而且整个过程会很慢,一切尽在不言中。<br>5.26投稿<br>5.29with editor<br>6.12还是with editor(发邮件催了一下)<br>7.2 under review(然后就有卡这了,发邮件催了2次还结果)<br>9月10号没想到突然就给了小修<br>9.22返修回去,一直with editor(都要放弃了,搞的都没脾气了)<br>最终11.12 accept。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822136, createdTime=Sun Dec 15 14:38:48 CST 2024, time=2024-12-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2249266, encodeId=ce5322492662a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:文章成功接收 分享下经验 <br>投稿类型:综述 实体瘤<br>12.4 submission<br>12.5 Send emails every day, modify the format, and then always with editor<br>12.14 Status updated around the day (date updated) Status is still with editor<br>12.16 under review 编辑邀请30+审稿人 有三位审稿人接收<br>1.9日 收到邮件 要求小修 审稿人十分友好 <br>1.20日提交返修<br>1.22文章接收<br>总体来说 这个杂志的速度是很快的 主编和审稿人非常友好!整个过程十分友好! 祝大家早日收到好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Thu Jan 23 09:20:06 CST 2025, time=2025-01-23, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2244413, encodeId=d21e22444132c, content=大家一般几位审稿人呀<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Sun Dec 22 23:22:43 CST 2024, time=2024-12-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2226088, encodeId=d04a2226088be, content=偏重的研究方向:肿瘤;实体肿瘤<br>经验分享:这杂志编辑去哪里了?with editor两个月没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54b86386942, createdName=ms9000000642329370, createdTime=Mon Sep 16 17:38:15 CST 2024, time=2024-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2242220, encodeId=6a1722422200c, content=状态记录12.05 with editor 至今仍然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Fri Dec 13 10:27:58 CST 2024, time=2024-12-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0<br>偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor状态持续两个半月,然后直接拒稿,白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京)]
    2024-09-16 ms9000000642329370

    偏重的研究方向:肿瘤;实体肿瘤
    经验分享:这杂志编辑去哪里了?with editor两个月没动静

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2242612, encodeId=867e22426124f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:记录一下,这个杂志社只收综述,而且整个过程会很慢,一切尽在不言中。<br>5.26投稿<br>5.29with editor<br>6.12还是with editor(发邮件催了一下)<br>7.2 under review(然后就有卡这了,发邮件催了2次还结果)<br>9月10号没想到突然就给了小修<br>9.22返修回去,一直with editor(都要放弃了,搞的都没脾气了)<br>最终11.12 accept。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822136, createdTime=Sun Dec 15 14:38:48 CST 2024, time=2024-12-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2249266, encodeId=ce5322492662a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:文章成功接收 分享下经验 <br>投稿类型:综述 实体瘤<br>12.4 submission<br>12.5 Send emails every day, modify the format, and then always with editor<br>12.14 Status updated around the day (date updated) Status is still with editor<br>12.16 under review 编辑邀请30+审稿人 有三位审稿人接收<br>1.9日 收到邮件 要求小修 审稿人十分友好 <br>1.20日提交返修<br>1.22文章接收<br>总体来说 这个杂志的速度是很快的 主编和审稿人非常友好!整个过程十分友好! 祝大家早日收到好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Thu Jan 23 09:20:06 CST 2025, time=2025-01-23, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2244413, encodeId=d21e22444132c, content=大家一般几位审稿人呀<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Sun Dec 22 23:22:43 CST 2024, time=2024-12-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2226088, encodeId=d04a2226088be, content=偏重的研究方向:肿瘤;实体肿瘤<br>经验分享:这杂志编辑去哪里了?with editor两个月没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54b86386942, createdName=ms9000000642329370, createdTime=Mon Sep 16 17:38:15 CST 2024, time=2024-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2242220, encodeId=6a1722422200c, content=状态记录12.05 with editor 至今仍然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Fri Dec 13 10:27:58 CST 2024, time=2024-12-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0<br>偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor状态持续两个半月,然后直接拒稿,白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京)]
    2024-12-13 ms1000000794282034 来自湖南省

    状态记录12.05 with editor 至今仍然是with editor

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2242612, encodeId=867e22426124f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:记录一下,这个杂志社只收综述,而且整个过程会很慢,一切尽在不言中。<br>5.26投稿<br>5.29with editor<br>6.12还是with editor(发邮件催了一下)<br>7.2 under review(然后就有卡这了,发邮件催了2次还结果)<br>9月10号没想到突然就给了小修<br>9.22返修回去,一直with editor(都要放弃了,搞的都没脾气了)<br>最终11.12 accept。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822136, createdTime=Sun Dec 15 14:38:48 CST 2024, time=2024-12-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2249266, encodeId=ce5322492662a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:文章成功接收 分享下经验 <br>投稿类型:综述 实体瘤<br>12.4 submission<br>12.5 Send emails every day, modify the format, and then always with editor<br>12.14 Status updated around the day (date updated) Status is still with editor<br>12.16 under review 编辑邀请30+审稿人 有三位审稿人接收<br>1.9日 收到邮件 要求小修 审稿人十分友好 <br>1.20日提交返修<br>1.22文章接收<br>总体来说 这个杂志的速度是很快的 主编和审稿人非常友好!整个过程十分友好! 祝大家早日收到好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Thu Jan 23 09:20:06 CST 2025, time=2025-01-23, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2244413, encodeId=d21e22444132c, content=大家一般几位审稿人呀<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Sun Dec 22 23:22:43 CST 2024, time=2024-12-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2226088, encodeId=d04a2226088be, content=偏重的研究方向:肿瘤;实体肿瘤<br>经验分享:这杂志编辑去哪里了?with editor两个月没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54b86386942, createdName=ms9000000642329370, createdTime=Mon Sep 16 17:38:15 CST 2024, time=2024-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2242220, encodeId=6a1722422200c, content=状态记录12.05 with editor 至今仍然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Fri Dec 13 10:27:58 CST 2024, time=2024-12-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0<br>偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor状态持续两个半月,然后直接拒稿,白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京)]
    2023-09-13 气管支气管 来自江西省

    审稿速度:12.0 | 投稿命中率:50.0
    偏重的研究方向:血液;肿瘤;综述
    经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,
    2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。
    终于在2023.09.12 accept。
    总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2242612, encodeId=867e22426124f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:记录一下,这个杂志社只收综述,而且整个过程会很慢,一切尽在不言中。<br>5.26投稿<br>5.29with editor<br>6.12还是with editor(发邮件催了一下)<br>7.2 under review(然后就有卡这了,发邮件催了2次还结果)<br>9月10号没想到突然就给了小修<br>9.22返修回去,一直with editor(都要放弃了,搞的都没脾气了)<br>最终11.12 accept。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822136, createdTime=Sun Dec 15 14:38:48 CST 2024, time=2024-12-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2249266, encodeId=ce5322492662a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:文章成功接收 分享下经验 <br>投稿类型:综述 实体瘤<br>12.4 submission<br>12.5 Send emails every day, modify the format, and then always with editor<br>12.14 Status updated around the day (date updated) Status is still with editor<br>12.16 under review 编辑邀请30+审稿人 有三位审稿人接收<br>1.9日 收到邮件 要求小修 审稿人十分友好 <br>1.20日提交返修<br>1.22文章接收<br>总体来说 这个杂志的速度是很快的 主编和审稿人非常友好!整个过程十分友好! 祝大家早日收到好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Thu Jan 23 09:20:06 CST 2025, time=2025-01-23, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2244413, encodeId=d21e22444132c, content=大家一般几位审稿人呀<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Sun Dec 22 23:22:43 CST 2024, time=2024-12-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2226088, encodeId=d04a2226088be, content=偏重的研究方向:肿瘤;实体肿瘤<br>经验分享:这杂志编辑去哪里了?with editor两个月没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54b86386942, createdName=ms9000000642329370, createdTime=Mon Sep 16 17:38:15 CST 2024, time=2024-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2242220, encodeId=6a1722422200c, content=状态记录12.05 with editor 至今仍然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Fri Dec 13 10:27:58 CST 2024, time=2024-12-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0<br>偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor状态持续两个半月,然后直接拒稿,白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京)]
    2024-01-31 ms2000000592007598 来自浙江省

    偏重的研究方向:肿瘤
    经验分享:12月15日投稿,到现在还是with editor

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2242612, encodeId=867e22426124f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:记录一下,这个杂志社只收综述,而且整个过程会很慢,一切尽在不言中。<br>5.26投稿<br>5.29with editor<br>6.12还是with editor(发邮件催了一下)<br>7.2 under review(然后就有卡这了,发邮件催了2次还结果)<br>9月10号没想到突然就给了小修<br>9.22返修回去,一直with editor(都要放弃了,搞的都没脾气了)<br>最终11.12 accept。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822136, createdTime=Sun Dec 15 14:38:48 CST 2024, time=2024-12-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2249266, encodeId=ce5322492662a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:文章成功接收 分享下经验 <br>投稿类型:综述 实体瘤<br>12.4 submission<br>12.5 Send emails every day, modify the format, and then always with editor<br>12.14 Status updated around the day (date updated) Status is still with editor<br>12.16 under review 编辑邀请30+审稿人 有三位审稿人接收<br>1.9日 收到邮件 要求小修 审稿人十分友好 <br>1.20日提交返修<br>1.22文章接收<br>总体来说 这个杂志的速度是很快的 主编和审稿人非常友好!整个过程十分友好! 祝大家早日收到好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Thu Jan 23 09:20:06 CST 2025, time=2025-01-23, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2244413, encodeId=d21e22444132c, content=大家一般几位审稿人呀<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Sun Dec 22 23:22:43 CST 2024, time=2024-12-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2226088, encodeId=d04a2226088be, content=偏重的研究方向:肿瘤;实体肿瘤<br>经验分享:这杂志编辑去哪里了?with editor两个月没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54b86386942, createdName=ms9000000642329370, createdTime=Mon Sep 16 17:38:15 CST 2024, time=2024-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2242220, encodeId=6a1722422200c, content=状态记录12.05 with editor 至今仍然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Fri Dec 13 10:27:58 CST 2024, time=2024-12-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0<br>偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor状态持续两个半月,然后直接拒稿,白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京)]
    2023-12-17 ms7000000544050302 来自湖北省

    审稿速度:3.0
    偏重的研究方向:综述;血液肿瘤
    经验分享:with editor状态持续两个半月,然后直接拒稿,白白浪费我三个月时间。谨慎投稿吧。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2242612, encodeId=867e22426124f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:记录一下,这个杂志社只收综述,而且整个过程会很慢,一切尽在不言中。<br>5.26投稿<br>5.29with editor<br>6.12还是with editor(发邮件催了一下)<br>7.2 under review(然后就有卡这了,发邮件催了2次还结果)<br>9月10号没想到突然就给了小修<br>9.22返修回去,一直with editor(都要放弃了,搞的都没脾气了)<br>最终11.12 accept。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822136, createdTime=Sun Dec 15 14:38:48 CST 2024, time=2024-12-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2249266, encodeId=ce5322492662a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:文章成功接收 分享下经验 <br>投稿类型:综述 实体瘤<br>12.4 submission<br>12.5 Send emails every day, modify the format, and then always with editor<br>12.14 Status updated around the day (date updated) Status is still with editor<br>12.16 under review 编辑邀请30+审稿人 有三位审稿人接收<br>1.9日 收到邮件 要求小修 审稿人十分友好 <br>1.20日提交返修<br>1.22文章接收<br>总体来说 这个杂志的速度是很快的 主编和审稿人非常友好!整个过程十分友好! 祝大家早日收到好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Thu Jan 23 09:20:06 CST 2025, time=2025-01-23, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2244413, encodeId=d21e22444132c, content=大家一般几位审稿人呀<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Sun Dec 22 23:22:43 CST 2024, time=2024-12-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2226088, encodeId=d04a2226088be, content=偏重的研究方向:肿瘤;实体肿瘤<br>经验分享:这杂志编辑去哪里了?with editor两个月没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54b86386942, createdName=ms9000000642329370, createdTime=Mon Sep 16 17:38:15 CST 2024, time=2024-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2242220, encodeId=6a1722422200c, content=状态记录12.05 with editor 至今仍然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Fri Dec 13 10:27:58 CST 2024, time=2024-12-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0<br>偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor状态持续两个半月,然后直接拒稿,白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京)]
    2023-10-18 ms7000000544050302 来自湖北省

    偏重的研究方向:综述;血液肿瘤
    经验分享:with editor一个月、催稿两次,目前还没有消息,服了。

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2242612, encodeId=867e22426124f, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:记录一下,这个杂志社只收综述,而且整个过程会很慢,一切尽在不言中。<br>5.26投稿<br>5.29with editor<br>6.12还是with editor(发邮件催了一下)<br>7.2 under review(然后就有卡这了,发邮件催了2次还结果)<br>9月10号没想到突然就给了小修<br>9.22返修回去,一直with editor(都要放弃了,搞的都没脾气了)<br>最终11.12 accept。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822136, createdTime=Sun Dec 15 14:38:48 CST 2024, time=2024-12-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2249266, encodeId=ce5322492662a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:文章成功接收 分享下经验 <br>投稿类型:综述 实体瘤<br>12.4 submission<br>12.5 Send emails every day, modify the format, and then always with editor<br>12.14 Status updated around the day (date updated) Status is still with editor<br>12.16 under review 编辑邀请30+审稿人 有三位审稿人接收<br>1.9日 收到邮件 要求小修 审稿人十分友好 <br>1.20日提交返修<br>1.22文章接收<br>总体来说 这个杂志的速度是很快的 主编和审稿人非常友好!整个过程十分友好! 祝大家早日收到好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Thu Jan 23 09:20:06 CST 2025, time=2025-01-23, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2244413, encodeId=d21e22444132c, content=大家一般几位审稿人呀<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Sun Dec 22 23:22:43 CST 2024, time=2024-12-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2226088, encodeId=d04a2226088be, content=偏重的研究方向:肿瘤;实体肿瘤<br>经验分享:这杂志编辑去哪里了?with editor两个月没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54b86386942, createdName=ms9000000642329370, createdTime=Mon Sep 16 17:38:15 CST 2024, time=2024-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2242220, encodeId=6a1722422200c, content=状态记录12.05 with editor 至今仍然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Fri Dec 13 10:27:58 CST 2024, time=2024-12-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0<br>偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor状态持续两个半月,然后直接拒稿,白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京)]
    2023-07-04 ms2000002077912665 来自北京

    偏重的研究方向:肿瘤;胃癌
    经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新

    1

    展开1条回复
共79条页码: 1/8页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分